1분 NEJM 리뷰 ep.5 Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis

30초 NEJM 리뷰 ep.5 Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis #shortsПодробнее

FDA Approves Mirikizumab, a Promising Induction and Maintenance Therapy for Ulcerative ColitisПодробнее

FDA Approves Mirikizumab, a Promising Induction and Maintenance Therapy for Ulcerative ColitisПодробнее

Newer therapies on the horizon for Inflammtory Bowel DiseaseПодробнее

Novel Targets and Therapeutic Perspectives in IBD: Beyond Anti-TNFПодробнее

Treating Acute Flaccid Myelitis With The NeubieПодробнее

How to Manage Ulcerative Colitis Without MedicationПодробнее